and/or

21 News Items found

In the Clinic

CAR Therapy for Solid Tumors Draws Attention at Annual Cancer Conference

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

Scientific Image

In the Lab

MSK Scientists Build "Armored" CAR T Cells to Smite Solid Tumors

The engineered immune cells secrete powerful drugs as a layer of defense.

MSK physician-scientist Renier Brentjens

Feature

Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy

An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.

MSK cell manufacturing specialist Xiuyan Wang

In the Lab

CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.

CAR T cells attacking cancer

In the Lab

New Immunotherapy Approach Turns Cells into “Micro-Pharmacies”

A new immunotherapy approach involves engineering CAR T cells to produce proteins that treat lymphoma.

Illustration of CAR T cells with conveyor belts leading out of them carrying HVEM protein in tablet form.

In the Clinic

CAR T Cell Therapies Are a Growing Area of Research

Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.

CAR T cell therapy

In the Lab

Seeing the Light: How Engineered Nerve Cells Might Curb Parkinson’s Disease

A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.

Neurons created from embryonic stem cells

Finding

Immunotherapy Shows Promise for Treating Solid Tumors in the Chest

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

Michel Sadelain and Prasad Adusumilli